Yan Shi

Dr. Yan Shi


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2022 in Microbiological Research
Verified
Journal Article
Closed access
XRXinran Ren
Xinran Ren
XGXuerui Guo
Xuerui Guo
CLChang Liu
Chang Liu
SJShisong Jing
Shisong Jing
TWTiedong Wang
Tiedong Wang
YSYan Shi
Yan Shi

28 January 2019 in Molecules
Verified
Journal Article
Open access
PDF file
JWJunxian Wang
Junxian Wang
YSYan Shi
Yan Shi
SJShisong Jing
Shisong Jing
HDHaisi Dong
Haisi Dong
QWQianxue Wang
Qianxue Wang
TWTiedong Wang
Tiedong Wang
Streptococcus mutans (S. mutans) is the primary etiological agent of dental caries. The S. mutans enzyme sortase A (SrtA) is responsible for anchoring bacterial cell wall surface proteins involved in host cell attachment and biofilm formation. Thus, SrtA is an attractive target for inhibiting dental caries caused by S. mutans-associated acid fermentation. In this study, we observed that astilbin, a flavanone compound extracted from Rhizoma Smilacis Glabrae, has potent inhibitory activity against the S. mutans SrtA, with an IC50 of 7.5 μg/mL. In addition, astilbin was proven to reduce the formation of biofilm while without affecting the growth of S. mutans. The results of a molecular dynamics simulation and a mutation analysis revealed that the Arg213, Leu111, and Leu116 of SrtA are important for the interaction between SrtA and astilbin. The results of this study demonstrate the potential of using astilbin as a nonbactericidal agent to modulate pathogenicity of S. mutans by inhibiting the activity of SrtA.

9 August 2021 in Virulence
Verified
Journal Article
Open access
LWLi Wang
Li Wang
SJShisong Jing
Shisong Jing
HQHan Qu
Han Qu
KWKai Wang
Kai Wang
YJYajing Jin
Yajing Jin
QWQianxue Wang
Qianxue Wang
Drug-resistant pathogenic Staphylococcus aureus (S. aureus) has severely threatened human health and arouses widespread concern. Sortase A (SrtA) is an essential virulence factor of S. aureus, which is responsible for the covalent anchoring of a variety of virulence-related proteins to the cell wall. SrtA has always been regarded as an ideal pharmacological target against S. aureus infections. In this research, we have determined that orientin, a natural compound isolated from various medicinal plants, can effectively inhibit the activity of SrtA with an IC50 of 50.44 ± 0.51 µM. We further demonstrated that orientin inhibited the binding of S. aureus to fibrinogen and diminished biofilm formation and the attaching of Staphylococcal protein A (SpA) to the cell wall in vitro. Using the fluorescence quenching assay, we demonstrated a direct interaction between orientin and SrtA. Further mechanistic studies revealed that the residues Glu-105, Thr-93, and Cys-184 were the key sites for the binding of SrtA to orientin. Importantly, we demonstrated that treatment with orientin attenuated S. aureus virulence of in vivo and protected mice against S. aureus-induced lethal pneumonia. These findings indicate that orientin is a potential drug to counter S. aureus infections and limit the development of drug resistance.

1 October 2021 in Biochemical Pharmacology
Verified
Journal Article
Closed access
SJShisong Jing
Shisong Jing
LWLi Wang
Li Wang
TWTiedong Wang
Tiedong Wang
LFLianghai Fan
Lianghai Fan
LCLin Chen
Lin Chen
QWQianxue Wang
Qianxue Wang

27 February 2024 in npj Biofilms and Microbiomes
Verified
Journal Article
Open access
PDF file
XGXuerui Guo
Xuerui Guo
LWLi Wang
Li Wang
JZJinlong Zhang
Jinlong Zhang
QLQuan Liu
Quan Liu
BWBingmei Wang
Bingmei Wang
YSYan Shi
Yan Shi
Limitations in the clinical treatment of Staphylococcus aureus (S. aureus) infections have arisen due to the advent of antibiotic-resistant strains. Given the immense potential of therapeutic strategies targeting bacterial virulence, the role of MgrA as a pivotal virulence determinant in S. aureus-orchestrating resistance, adherence, and hundreds of virulence targets—becomes indispensable. In this investigation, leveraging advanced virtual screening and fluorescence anisotropy assays, we discerned methylophiopogonanone A (Mo-A), a flavonoid derivative, as a potent disruptor of the MgrA-DNA interaction nexus. Subsequent analysis revealed that Mo-A effectively inhibits the expression of virulence factors such as Hla and Pvl in S. aureus and markedly reduces its adhesion capability to fibrinogen. On a cellular landscape, Mo-A exerts a mitigating influence on the deleterious effects inflicted by S. aureus USA300 on A549 cells. Furthermore, our data indicate that Mo-A downregulates the transcription of genes associated with immune evasion, such as nucleases (nuc), Staphylococcal Chemotaxis Inhibitory Protein (chips), and Staphylococcal Complement Inhibitor (scin), thereby undermining immune escape and amplifying neutrophil chemotaxis. Upon application in an in vivo setting, Mo-A assumes a protective persona in a murine model of S. aureus USA300-induced pneumonia and demonstrates efficacy in the Galleria mellonella infection model. Of note, S. aureus displayed no swift acquisition of resistance to Mo-A, and the effect was synergistically enhanced when used in combination with vancomycin. Our findings add substantive weight to the expanding field of virulence-targeted therapeutic strategies and set the stage for more comprehensive exploration of Mo-A potential in combating antibiotic-resistant S. aureus.

1 November 2021 in Phytomedicine
Verified
Journal Article
Closed access
CCChen Chen
Chen Chen
JMJiulong Ma
Jiulong Ma
CMChun Sheng Miao
Chun Sheng Miao
HZHuayu Zhang
Huayu Zhang
MZMing Zhang
Ming Zhang
YSYan Shi
Yan Shi